Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report.

Oral oncology - 1 Nov 2023

Yu Wenyan, Ding Changli, Li Kaichun

Abstract excerpt

BACKGROUND: Carcinoma ex pleomorphic adenoma (CXPA) is a neoplasm of the salivary gland that causes 3.6% of salivary gland tumors and 12% of salivary gland malignancies. Its prognosis is determined by the histological progression beyond the adenoma capsule. CXPA is thought to be a malignant transformation of a primary or recurrent pleomorphic adenoma and is associated with both benign and malignant lesions....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Genes, erbB-2
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Palliative Care

Share to Salivary Gland Neoplasms

Source

Identifiers

PMID: 37595449
DOI: 10.1016/j.oraloncology.2023.106541

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report.PMID 37595449Read ↗

Salivary gland cancers: current treatments, molecular characteristics and new therapies.Semantic proximity Read ↗

Molecular profile of a pleomorphic adenoma of the hard palateSemantic proximity Read ↗

Salivary Gland Cancers: Biology and Molecular Targets for TherapySemantic proximity Read ↗

[Salivary gland cancer: new therapeutic approaches].Semantic proximity Read ↗

Salivary gland cancer: an update on present and emerging therapies.Semantic proximity Read ↗

Salivary gland carcinoma: Towards a more personalised approach.Semantic proximity Read ↗

Malignant transformation of salivary gland pleomorphic adenoma: proof of principleSemantic proximity Read ↗

Carcinoma ex Pleomorphic Adenoma: A Comprehensive Review of Clinical, Pathological and Molecular DataSemantic proximity Read ↗

Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.Semantic proximity Read ↗

Insights into the molecular alterations of PLAG1 and HMGA2 associated with malignant phenotype acquisition in pleomorphic adenoma.Semantic proximity Read ↗

Single-cell transcriptomic analysis uncovers the origin and intratumoral heterogeneity of parotid pleomorphic adenomaSemantic proximity Read ↗

Update in salivary gland cytopathology: Recent molecular advances and diagnostic applications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.